Literature DB >> 7099711

The anti-neoplastic effect of trichinellosis in a syngeneic murine model.

D Pocock, E Meerovitch.   

Abstract

C57BL/6 male mice with chronic trichinellosis, and age-matched uninfected control mice, were inoculated with B16 melanoma cells. Tumour development was inhibited in the infected animals. In the infected tumour-bearing mice, the tumor induction intervals were longer and the tumour size was subsequently smaller than in the control mice. Moreover, when the number of tumour cells in the inoculum was less than that required to produce 100% tumour incidence in the uninfected mice (less than 1 x 10(4) cells), significantly more of the mice with an infection of 2 months duration remained tumour-free. These results were significant at the P less than 0.05 level.

Entities:  

Mesh:

Year:  1982        PMID: 7099711     DOI: 10.1017/s0031182000052768

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  4 in total

1.  Pattern of proinflammatory cytokine mRNA expression during Trichinella spiralis infection of the rat.

Authors:  A W Stadnyk; J A Kearsey
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

Review 2.  Secretory Products of Trichinella spiralis Muscle Larvae and Immunomodulation: Implication for Autoimmune Diseases, Allergies, and Malignancies.

Authors:  Ljiljana Sofronic-Milosavljevic; Natasa Ilic; Elena Pinelli; Alisa Gruden-Movsesijan
Journal:  J Immunol Res       Date:  2015-05-31       Impact factor: 4.818

3.  Necrosis and apoptosis in Trichinella spiralis-mediated tumour reduction.

Authors:  Sasa Vasilev; Natasa Ilic; Alisa Gruden-Movsesijan; Sasa Vasilijic; Martina Bosic; Ljiljana Sofronic-Milosavljevic
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

4.  Anti-Tumor Effect of Marshallagia marshalli Somatic Antigen on Inhibition Cell Growth of K562.

Authors:  Reyhane Raisnia; Hadi Mohebalian; Atousa Shahrokhi Sabzevar; Hassan Borji
Journal:  Iran J Parasitol       Date:  2022 Jan-Mar       Impact factor: 1.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.